DEP AR TMENT F OR INTERNATIONAL T RADE
The Need for Cancer Care and How NHS Innovations are Tackling this
Growing and ageing populations mean the need for cancer care is increasing – and our patients rightfully expect more from our medical services. We have seen great advances in technology, in the UK, with an increase in digital apps, genetic testing and diagnostic infrastructure helping people get diagnosed earlier. Some of the UK’s leading cancer hospitals
are able to share over 70 years’ experience and innovation, and research-based clinical pathways, utilising the most advanced science, training, equipment and digital systems. They are making sure their patients are getting the care they deserve and these innovations are leading to decreased mortality rates and better outcomes for cancer patients. Sadly, many of those at risk or already suffering
from cancer do not always seek medical diagnosis early enough in the UK. A key NHS innovation is to bring this help to the patients in their own communities. As an example, one NHS Trust and study
showed only 18% of cancers were being diagnosed at stage one, while 48% were being diagnosed at stage four. Following the introduction of a mobile screening programme, stage one diagnoses increased significantly to 68%. Here are some of the ways our NHS Trusts are
identifying at-risk patients more easily: n We have found that digitally enabled pathology speeds up diagnosis - e.g., MRI scans and targeted biopsies speed up diagnosis of prostate cancer to no more than 10 days.
n Embedding patient supplied data into care pathways reduces the need for outpatient appointments, while increasing detection rates.
n Genetic testing hubs and rapid diagnostic centres can also help diagnose patients quicker. n Providing patients with direct and remote digital
DUB AI 2023
health services (access to aftercare) can reduce unnecessary outpatient appointments and increase access to further tests and medical assessment where needed.
Our NHS teams can provide expert support with these areas, and more. This might be new surgical techniques; for example, reducing oesophageal cancer though a new non-invasive procedure, or bringing the hospital together with universities and industry to scale up advanced precision therapies or introducing biosimilars to reduce pharmaceutical costs. These innovations promote new research and best practice, and enable access to new methods into hospitals. Here are some more specific examples of the
UK’s many innovation programmes: n Advanced training - The Christie’s genomic medicine and transformative oncology programme.
n Clinical leadership - Royal Marsden’s leading cancer care programme.
n Digital systems and advanced infrastructure - Proton beam therapy centres.
n Leading university research - Genomics research data programme.
n UK NHS National Programmes include: - Smoking rates at their lowest level of 13.5% (Jan- March 2020). - NHS ‘one-stop-shops’ delivered over 1 million checks and tests in their first year. - Genetic testing and personalised care offered by 83% of NHS multidisciplinary teams.
For more information and to share experiences, we would be delighted to put you in touch with the relevant teams, please do get in touch with us:
healthcare.uk@
trade.gov.uk
UKHEALT HCAREPA VILION. COM 13
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52 |
Page 53 |
Page 54 |
Page 55 |
Page 56 |
Page 57 |
Page 58
